Renal Stones, Idiopathic Hypercalciuria
Conditions
Keywords
recurrent renal stones, idiopathic hypercalciuria, nano-water, hydrochlorthiazide
Brief summary
We assessed the effect of structured nano-water in the prevention of recurrent stone formation in patients with recurrent calcium oxalate stones and hypercalciuria.
Detailed description
The majority of stones (85%) contain primarily calcium oxalate. Most renal stones are idiopathic calcium stones, and the most common predisposing factor in these patients is hypercalciuria. Structured nano-water is a new type of water that has been prepared using different types of energy fields electromagnetic fields to produce this structured nano- water that has new and different characteristics from the ordinary water. In this study, we compared the efficacy of the nano- water with hydrochlorothiazide and with ordinary bottled drinking water in the prevention of recurrent renal stones in patients with idiopathic hypercalciuria. We conducted a three-year randomized trial comparing the effect of structured water with the effect of hydrochlorothiazide and ordinary bottled water in 325 patients with recurrent calcium oxalate stones and hypercalciuria. The patients were randomly divided into three groups. Group A included 108 patients who used structured nano-water in a dose of 20 mL/kg as a daily dose. Group B of 107 patients used 50 mg hydrochlorothiazide tablets as a daily dose, and group C consisted of another 110 patients used ordinary drinking bottled water in a daily dose of 20 mL/kg . The assessments were done by urine analysis with renal ultrasonography and radiology ( Kidney Ureter Bladder KUB X-rays) were done at baseline, at yearly intervals, also at any time of recurrence, and at the end of the 3 years (36th month). The patients, care providers, and the investigators were blinded about the type of water used since the water bottles were unlabeled when given to the patients. All patients were informed and signed a written informed consent form.
Interventions
DIETARY_SUPPLEMENTstructured nano-water
Hydrochlorothiazide is a drug used to prevent recurrent renal stone formation in patients with idiopathic hypercalciuria
hydrochlorothiazide is a drug used to prevent recurrent stone formation i patients with idiopathic hypercalciuria
Patients with idiopathic hypercalciuria receiving regular bottled drinking water as a placebo to see its effect.
Sponsors
ALI KAMAL M. SAMI
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Masking description
neither the participants nor the investigators or the care givers and the outcome assessors knew the group of patients
Intervention model description
Three groups that run parallel and receive the different allocated modalities and are followed up for three consecutive years
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Idiopathic hypercalciuria * history of previous renal stones
Exclusion criteria
* already present renal stones * previous surgery of the kidneys * Congenital anomalies of the urinary system * Renal failure * Allergy to hydrochlorothiazide
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Recurrent renal stones | From enrollment to the end of treatment at 36 months | recurrent renal stone were diagnosed by ultrasound and X-ray ( kidney ureter Bladder X-ray) |
Countries
Iraq
Outcome results
None listed